EquityZen Growth Technology Fund LLC - Series 1253
Raised
$179K
Investors
3
Min Invest
$1,022
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1253 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors LLC on 2022-04-06. The fund raised $179K from 3 investors with a $1K minimum investment, utilizing Rule 506(b) and 3(c)(1) exemptions. This is part of the EquityZen platform, which operates 1889+ related series SPVs for pre-IPO secondary market transactions.
This pre-IPO fund follows EquityZen's standard SPV template with Rule 506(b) and 3(c)(1) exemptions, a low $1K minimum typical of retail-accessible secondary share vehicles, and modest capital raise consistent with single-company exposure vehicles. The three-investor structure and sub-$200K raise align with EquityZen's high-volume, single-deal SPV model for fractionalizing private company shares.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.